According to the Zhitong Finance App, Yongsheng Healthcare (01612) announced its 2026 interim results. Revenue increased 7.1% year-on-year to approximately HK$482 million. Profit attributable to company owners reached HK$43.548 million, a year-on-year decrease of 15.65%; basic profit per share was 6.71 HK cents, with an interim dividend of HK2.0 cents per share.

According to the announcement, the increase in revenue was mainly driven by the imaging disposable products segment receiving more orders, which was enough to offset the decline in revenue in the surplus orthopedic support and rehabilitation equipment division and the respiratory products division. The decrease in profit was mainly due to initial operating expenses, system upgrades and depreciation of the new production facility, putting short-term pressure on profits. However, the Group believes that such initial expenses can improve long-term operational efficiency.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.